Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inertia. / Decálogo de la Sociedad Española de Arteriosclerosis para disminuir la inercia terapéutica.
Clin Investig Arterioscler
; 29(5): 218-223, 2017.
Article
em En, Es
| MEDLINE
| ID: mdl-28844490
Therapeutic inertia (TI) is defined as the failure of the physician to initiate or intensify a treatment when the therapeutic goal has not been achieved. TI can be of 2types: inertia due to lack of prescription of drugs and inertia in the absence of control of a risk factor. The consequences of TI are poor control of risk factors, an increase in potentially preventable events and an increase in costs. There are factors of the doctor himself, the patient and the care organization that determine the presence of TI. Ten measures are proposed to reduce TI: to promote continuing education, to define clearly therapeutic objectives, to establish audits, to implement computerized medical records with alerts, to encourage research in this field, to disseminate clinical practice guidelines, to create motivational incentives, to organize care, to improve the doctor-patient relationship and to involve other health care providers.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
14_ODS3_health_workforce
/
1_ASSA2030
/
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Relações Médico-Paciente
/
Médicos
/
Arteriosclerose
/
Guias de Prática Clínica como Assunto
Tipo de estudo:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
/
Es
Revista:
Clin Investig Arterioscler
Ano de publicação:
2017
Tipo de documento:
Article